ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,283Medicare Part D Prescriptions Filled, Including Refills

Rank: 255 out of 2888

$785K Total Retail Price of All Prescriptions

Rank: 378 out of 2888

508 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 508 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 11,787 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
AMLODIPINE BESYLATE 734 642 1 5
SIMVASTATIN 547 456 2 2
METOPROLOL TARTRATE 478 422 3 10
METFORMIN HCL 477 405 4 8
METOPROLOL SUCCINATE 440 381 5 11
ATORVASTATIN CALCIUM 437 385 6 9
HYDROCODONE-ACETAMINOPHEN 399 260 S3 7 4
LEVOTHYROXINE SODIUM 396 297 8 1
BENAZEPRIL HCL 326 280 9 77
OMEPRAZOLE 318 234 10 7
FUROSEMIDE 312 290 11 6
LISINOPRIL 286 241 12 3
LISINOPRIL-HYDROCHLOROTHIAZIDE 262 224 13 28
BENAZEPRIL-HYDROCHLOROTHIAZIDE 261 229 14 254
TAMSULOSIN HCL 239 209 15 29
AMLODIPINE BESYLATE-BENAZEPRIL 202 179 16 67
PRAVASTATIN SODIUM 202 135 16 12
CARVEDILOL 194 169 18 21
HYDRALAZINE HCL 174 163 19 59
GLYBURIDE 169 155 R 20 58
DIOVAN HCT 162 138 21 61
GLIMEPIRIDE 161 147 22 36
LOVASTATIN 160 156 23 41
CRESTOR 158 113 24 20
PANTOPRAZOLE SODIUM 150 135 25 33
ALLOPURINOL 143 138 26 37
JANUVIA 143 109 26 48
GLYBURIDE-METFORMIN HCL 137 96 R 28 64
DIOVAN 136 113 29 35
FELODIPINE ER 128 125 30 175
HYDROCHLOROTHIAZIDE 127 107 31 15
LANTUS 127 94 31 45
NIFEDIPINE ER 122 107 33 76
CLOPIDOGREL 109 98 34 30
GLIPIZIDE 109 79 34 50
CITALOPRAM HBR 104 78 36 24
BENICAR 96 94 37 138
LANTUS SOLOSTAR 95 62 38 92
ACTONEL 93 81 39 149
TRAMADOL HCL 93 61 39 16
VYTORIN 92 92 41 155
CLONIDINE HCL 91 91 42 39
NEXIUM 90 89 43 19
FENOFIBRATE 86 38 44 65
DONEPEZIL HCL 84 81 45 26
SERTRALINE HCL 82 63 46 27
INSULIN SYRINGE 76 61 47 86
POTASSIUM CHLORIDE 73 54 48 14
GEMFIBROZIL 69 69 49 98
RANITIDINE HCL 66 35 50 56
GABAPENTIN 65 30 51 13
VERAPAMIL ER 65 58 51 104
BENICAR HCT 64 64 53 181
ISOSORBIDE MONONITRATE ER 64 62 53 51
FINASTERIDE 64 64 53 102
PLAVIX 64 54 53 40
DOXAZOSIN MESYLATE 63 50 57 94
LOSARTAN POTASSIUM 61 61 58 18
NIFEDIAC CC 60 56 59 300
DIGOXIN 59 47 60 55
EXFORGE 55 45 61 159
PEN NEEDLE 53 28 62 110
CYMBALTA 52 35 63 44
ALENDRONATE SODIUM 52 51 63 23
PAROXETINE HCL 51 50 65 84
ZOLPIDEM TARTRATE 51 36 65 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.